SCHEMBL2909824

SCHEMBL2909824

C[C@H](CO)NC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(C(F)(F)F)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 3/20 0.39
FEN1 P39748 3/20 0.39
HDAC4 P56524 3/20 0.35
HDAC6 Q9UBN7 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
PKM P14618 1/20 0.35
GSK3B P49841 2/20 0.33
GSK3A P49840 1/20 0.33
MAPK1 P28482 1/20 0.33
MAPT P10636 4/20 0.33
THRB P10828 1/20 0.33
MET P08581 1/20 0.32
AXL P30530 1/20 0.32
ALDH1A1 P00352 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HTT P42858 3/20 0.31
RAB9A P51151 1/20 0.31
MYC P01106 1/20 0.31
MAX P61244 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2913352 1.00 ALOX5AP (0.39) ALOX5APFEN1HDAC4HDAC6MEN1
SCHEMBL2911193 0.92 MET (0.35) ALOX5APFEN1HDAC4HDAC6GSK3B
SCHEMBL2904127 0.92 MET (0.35) ALOX5APFEN1HDAC4HDAC6GSK3B
SCHEMBL2912533 0.91 GSK3B (0.34) ALOX5APFEN1GSK3BGSK3AMAPK1
SCHEMBL2909788 0.91 GSK3B (0.34) ALOX5APFEN1GSK3BGSK3AMAPK1
SCHEMBL2904400 0.91 ALOX5AP (0.43) ALOX5APFEN1HDAC4HDAC6MEN1
SCHEMBL2912014 0.91 ALOX5AP (0.43) ALOX5APFEN1HDAC4HDAC6MEN1
SCHEMBL2913577 0.91 AHR (0.37) ALOX5APFEN1HDAC4HDAC6MEN1
SCHEMBL2911914 0.91 AHR (0.37) ALOX5APFEN1HDAC4HDAC6MEN1
SCHEMBL2911532 0.90 ALDH1A1 (0.41) MEN1KMT2AGSK3BGSK3AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed